Relation between plasma antioxidant vitamin levels, adiposity and cardio-metabolic profile in adolescents: Effects of a multidisciplinary obesity programme

Clinical Nutrition

Volumn 36, Issue 1, 2017, Pages 209-217

  Guerendiain, Marcela ^a,b   Mayneris Perxachs, Jordi ^a   Montes, Rosa ^a,e   López Belmonte, Gemma ^c   Martín Matillas, Miguel ^c,d   Castellote, Ana I ^a,e   Martín Bautista, Elena ^d   Martí, Amelia ^e,f   Martínez, J Alfredo ^e,f   Moreno, Luis ^g   Garagorri, Jesús Mª ^g   Wärnberg, Julia ^h   Caballero, Javier ⁱ   Marcos, Ascensión ^h   López Sabater, M Carmen ^a,e   Campoy, Cristina ^c,d,j  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^c UNIVERSITY OF GRANADA   (Spain)

^d EURISTIKOS Excellence Centre for Paediatric Research   (Spain)

^e Instituto de Salud Carlos III   (Spain)

^f UNIVERSITY OF NAVARRA   (Spain)

^g UNIVERSITY OF ZARAGOZA   (Spain)

^h INSTITUTE OF FOOD SCIENCE   (Spain)

ⁱ HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^j CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

more..

Author keywords

Cardio metabolic profile; Obese adolescents; Plasma antioxidant vitamins; Plasma carotenoids; Weight loss

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; LYCOPENE; RETINOL; VITAMIN; APOLIPOPROTEIN; CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE; CARDIOMETABOLIC RISK; CHILD; CONTROLLED STUDY; DIETARY INTAKE; DISEASE MARKER; FAT MASS; FEMALE; HEALTH PROGRAM; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; THERAPY EFFECT; VITAMIN BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASE; CHILDHOOD OBESITY; COHORT ANALYSIS; DIET; FOLLOW UP; METABOLIC SYNDROME X; NUTRITIONAL ASSESSMENT; RISK FACTOR;

ADIPOSITY; ADOLESCENT; ALPHA-TOCOPHEROL; ANTHROPOMETRY; ANTIOXIDANTS; APOLIPOPROTEINS; BETA CAROTENE; CARDIOVASCULAR DISEASES; CAROTENOIDS; CHILD; CHOLESTEROL; COHORT STUDIES; DIET; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME; NUTRITION ASSESSMENT; OVERWEIGHT; PEDIATRIC OBESITY; RISK FACTORS; TRIGLYCERIDES; VITAMIN A; VITAMINS;

EID: 85020736809     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.11.001     Document Type: Article

References (30)

1. WHO, Population-based prevention strategies for childhood obesity: report of a WHO forum and technical meeting., 2010, World Health Organization, Geneva.
2. Mathieu, P., Lemieux, I., Després, J.P., Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 87 (2010), 407–416.
3. L'Allemand-Jander, D., Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child. Int J Obes 34 (2010), S32–S36.
4. Gordon-Larsen, P., Adair, L.S., Nelson, M.C., Popkin, B.M., Five-year obesity incidence in the transition period between adolescence and adulthood: the National Longitudinal Study of Adolescent Health. Am J Clin Nutr 80 (2004), 569–575.
5. Codoñer-Franch, P., Boix-García, L., Simó-Jordá, R., del Castillo-Villaescusa, C., Maset-Maldonado, J., Valls-Bellés, V., Is obesity associated with oxidative stress in children?. Int J Pediatr Obes 5 (2010), 56–63.
6. Molnar, D., Decsi, T., Koletzko, B., Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes 28 (2004), 1197–1202.
7. Yasmeen, R., Jeyakumar, S.M., Reichert, B., Yang, F., Ziouzenkova, O., The contribution of vitamin A to autocrine regulation of fat depots. Biochim Biophys Acta 1821 (2012), 190–197.
8. Lobo, G.P., Amengual, J., Li, H.N.M., Golczak, M., Bonet, M.L., Palczewski, K., et al. β,β-Carotene decreases peroxisome proliferator receptor γ activity and reduces lipid storage capacity of adipocytes in a β,β-carotene oxygenase 1-dependent manner. J Biol Chem 285 (2010), 27891–27899.
9. Gouranton, E., Thabuis, C., Riollet, C., Malezet-Desmoulins, C., El Yazidi, C., Amiot, M.J., et al. Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J Nutr Biochem 22 (2011), 642–648.
10. Pipaliya, H., Vaghasiya, J., Cardio protective effect of vitamin a against isoproterenol-induced myocardial infarction. J Nutr Sci Vitaminol (Tokyo) 58 (2012), 402–407.
11. Palozza, P., Parrone, N., Catalano, A., Simone, R., Tomato lycopene and inflammatory cascade: basic interactions and clinical implications. Curr Med Chem 17 (2010), 2547–2563.
12. Mordente, A., Guantario, B., Meucci, E., Silvestrini, A., Lombardi, E.E., Martorana, G., et al. Lycopene and cardiovascular diseases: an update. Curr Med Chem 18 (2011), 1146–1163.
13. Stahl, W., Junghans, A., de Boer, B., Driomina, E.S., Briviba, K., Sies, H., Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett 427 (1998), 305–308.
14. Calder, P.C., Albers, R., Antoine, J.M., Blum, S., Bourdet-Sicard, R., Ferns, G.A., et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 101 (2009), 1–45.
15. Zillikens, M.C., van Meurs, J.B.J., Rivadeneira, F., Hofman, A., Oostra, B.A., Sijbrands, E.J.G., et al. Interactions between dietary vitamin E intake and SIRT1 genetic variation influence body mass index. Am J Clin Nutr 91 (2010), 1387–1393.
16. Brigelius-Flohé, R., Vitamin E: the shrew waiting to be tamed. Free Radic Biol Med 46 (2009), 543–554.
17. Tim, J.C., Mary, C.B., Katherine, M.F., William, H.D., Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ, 320, 2000, 1240.
18. Martinez-Gomez, D., Gomez-Martinez, S., Puertollano, M.A., Nova, E., Warnberg, J., Veiga, O., et al. Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON study. BMC Public Health, 9, 2009, 414.
19. Tanner, J.M., Whitehouse, R.H., Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51 (1976), 170–179.
20. Topouchian, J.A., El Assaad, M.A., Orobinskaia, L.V., El Feghali, R.N., Asmar, R.G., Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT). Blood Press Monit 11 (2006), 165–171.
21. Wallach, J., Interpretation of diagnostic tests. 9th ed., 2011, Lippincott Williams & Wilkins, Philadelphia.
22. Walldius, G., Jungner, I., The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy – a review of the evidence. J Intern Med 259 (2006), 493–519.
23. Hong, K., Li, Z., Wang, H.J., Elashoff, R., Heber, D., Analysis of weight loss outcomes using VLCD in black and white overweight and obese women with and without metabolic syndrome. Int J Obes Relat Metab Disord 29 (2005), 436–442.
24. Codoner-Franch, P., Lopez-Jaen, A.B., De La Mano-Hernandez, A., Sentandreu, E., Simo-Jorda, R., Valls-Belles, V., Oxidative markers in children with severe obesity following low-calorie diets supplemented with mandarin juice. Acta Paediatr 99 (2010), 1841–1846.
25. Walldius, Gr, Jungner, I., Aastveit Are, H., Holme, I., Furberg Curt, D., Sniderman Allan, D., The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42 (2004), 1355–1363.
26. Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Meigs, J.B., et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 53 (2004), 1782–1789.
27. Othman, E.M., Kreissl, M.C., Kaiser, F.R., Arias-Loza, P.-A., Stopper, H., Insulin-mediated oxidative stress and DNA damage in LLC-PK1 pig kidney cell line, female rat primary kidney cells, and male ZDF rat kidneys in vivo. Endocrinology 154 (2013), 1434–1443.
28. Wunsch, R., de Sousa, G., Toschke, A.M., Reinehr, T., Intima-media thickness in obese children before and after weight loss. Pediatrics 118 (2006), 2334–2340.
29. Reinehr, T., de Sousa, G., Toschke, A.M., Andler, W., Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr 84 (2006), 490–496.
30. McGill, H.C., McMahan, C.A., Herderick, E.E., Malcom, G.T., Tracy, R.E., Strong, J.P., et al. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 72 (2000), 1307s–1315s.